Predicted to be involved in intracellular copper ion homeostasis. Predicted to be located in cytosol and mitochondrial intermembrane space. Orthologous to human COX19 (cytochrome c oxidase assembly factor COX19); INTERACTS WITH 2,3,7,8-tetrachlorodibenzodioxine; 3,4-methylenedioxymethamphetamine; bisphenol A.
COX19 cytochrome c oxidase assembly factor; COX19 cytochrome c oxidase assembly homolog; COX19 cytochrome c oxidase assembly homolog (S. cerevisiae); cytochrome c oxidase assembly factor; cytochrome c oxidase assembly homolog 19; cytochrome c oxidase assembly homolog 19 (S. cerevisiae); cytochrome c oxidase assembly protein 19; LOC304330; RGD1305631; similar to 2810437L13Rik protein
[[Gasoline co-treated with 1-Butanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of COX19 mRNA
[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of COX19 mRNA
[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of COX19 mRNA and [perfluorooctane sulfonic acid co-treated with Pectins] results in increased expression of COX19 mRNA
[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of COX19 mRNA
[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of COX19 mRNA